Vision and mission

Immunovia’s vision is to lead the way in bioinformatic-assisted diagnostics towards a future where all patients are diagnosed in time for effective treatment, better quality of life and significantly improved survival rates.

Therefore, our missions are:

  1. To discover, develop and establish more accurate and reliable tools for the early diagnosis of cancers and autoimmune disorders based on the IMMray™ platform to enable more effective treatment and better patient outcomes.
  2. To establish our blood-based test for the early diagnosis of pancreatic cancer – IMMray™ PanCan-d – as a global standard for detecting pancreatic cancer in high-risk groups much earlier than is possible today.

Subscribe to receive press releases and reports via email
To start your subscription you need to activate your e-mail address by clicking the link in the email that is sent to you after you have submitted this form.

Press releases
Financial reports